An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Código QR

An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Guardado en:

Detalles Bibliográficos
Autor principal:	ZHANG Yue
Formato:	article
Lenguaje:	ZH
Publicado:	Editorial Department of Journal of Clinical Hepatology 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/fd6b90a585fc4e9e9506cae0fe9ea498
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An excerpt of diagnosis, evaluation, and management of ascites and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
por: HU Jiaxuan
Publicado: (2021)

An excerpt of Budd-Chiari syndrome: Consensus guidance of the Asian Pacific Association for the Study of the Liver (APASL)
por: WANG Xueying
Publicado: (2021)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt SJ, et al.
Publicado: (2014)

Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis
por: YU Weiming
Publicado: (2021)

Transmission, diagnosis, and management of hepatitis E: an update
por: Mirazo S, et al.
Publicado: (2014)

Clinical features and prognosis of primary myelofibrosis with hepatic vascular disease and/or portal hypertension
por: WANG Jing
Publicado: (2021)

Epidemiology of drug-induced liver injury
por: LI Xiaoyun
Publicado: (2021)

Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
por: LI Pinhua
Publicado: (2021)

Clinical manifestations and typing of drug-induced liver injury
por: YANG Wanna
Publicado: (2021)

Drug-induced liver injury: Advances and confusions in treatment
por: CHEN Shuai
Publicado: (2021)

Pathological features and pathological diagnosis of drug-induced liver injury
por: YANG Yongfeng
Publicado: (2021)

Pathogenesis of drug-induced liver injury: Current understanding and future needs
por: YU Yuecheng
Publicado: (2021)

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
por: M Gabrovska, et al.
Publicado: (2009)

Clinical features of drug-induced liver failure and related diagnosis and treatment strategies
por: LAI Rongtao
Publicado: (2021)

Prevalence rate of non-obese fatty liver disease and related influencing factors
por: DENG Jiang
Publicado: (2021)

Autonomic dysfunction in chronic liver disease
por: Frith J, et al.
Publicado: (2011)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021)

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Shahla Rezaei, et al.
Publicado: (2021)

Construction of a new patient-derived xenograft model of human liver cancer in mice with normal immunity
por: TANG Huixin
Publicado: (2021)

A preliminary study on percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy in treatment of refractory liver abscess
por: DUAN Changhu
Publicado: (2021)

Systemic vascular resistance in cirrhosis: a predictor of severity?
por: Gaduputi V, et al.
Publicado: (2014)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke JE, et al.
Publicado: (2011)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
por: Bradford V, et al.
Publicado: (2013)

Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease
por: ZHANG Jie
Publicado: (2021)

Therapeutic effect of Taohong Siwu decoction on a mouse model of carbon tetrachloride-induced liver fibrosis and its mechanism
por: LIU Xuling
Publicado: (2021)

Severe acute ischemic colitis: What is the place of endoscopy in the management strategy?
por: Diane Lorenzo, et al.
Publicado: (2021)

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise
por: LI Meiying
Publicado: (2021)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka M, et al.
Publicado: (2015)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau T, et al.
Publicado: (2013)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011)

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
por: Durango E, et al.
Publicado: (2013)

Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis
por: Meredith M. Pearson, et al.
Publicado: (2021)

Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
por: Motoh Iwasa, et al.
Publicado: (2021)

Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
por: Azhar Hussain, et al.
Publicado: (2021)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021)

A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events
por: Hughes AN, et al.
Publicado: (2014)

Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition
por: Junichi Iwamoto, et al.
Publicado: (2021)

A newborn liver mass that never existed: a somber reminder of embryonic ties between umbilical vein and portal venous system
por: Haafiz A, et al.
Publicado: (2011)